益生菌:在乳病患者的无质饮食中补充的补充剂
Hasna Ait Said1,2, Lahcen Elmoumou1,2, Bouchra Rherissi3
1Molecular Engineering, Biotechnology and Innovation Team, Geo-Bio-Environment Engineering and Innovation Laboratory, Polydisciplinary Faculty of Taroudannt, IBN ZOHR University, Taroudannt City, Morocco.
Gastroenterology and hepatology from bed to bench
|October 21, 2025
概括
无质饮食是治疗乳的主要治疗方法,但益生菌可以提供辅助益处. 益生菌可能有助于管理肠道微生物群平衡,并减少腹患者的胃肠道症状.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 病是一种自身免疫性肠病,由摄入质引发.
- 遗传和环境因素影响着乳病的发病.
- 肠道功能失调被假设有助于乳病的发展和症状.
研究的目的:
- 审查无质饮食 (GFD) 作为乳病的主要治疗方法的作用.
- 探索益生菌作为辅助疗法的潜力,用于治疗腹腔疾病.
主要方法:
- 关于无质饮食有效性和挑战的文献综述.
- 对研究研究益生菌 (Lactobacillus,Bifidobacterium) 在乳病中的研究进行分析.
- 检查在乳病中益生菌作用的拟议机制.
主要成果:
- GFD对于预防症状和肠道愈合至关重要,但存在复杂性和污染风险等挑战.
- 益生菌作为辅助疗法具有前景,可能有助于质多的分解,并减少上皮细胞损伤.
- 益生菌可能有助于恢复肠道微生物群平衡,并缓解慢性胃肠道症状.
结论:
- 无质饮食仍然是乳病管理的基石.
- 益生菌通过支持肠道健康和控制症状,为乳患者提供潜在的附加益处.
- 需要进一步的研究,以充分阐明益生菌在乳病治疗中的作用.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
Drugs for Treatment of Constipation-Predominant IBS
712
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
712
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
429
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
429
What is Monogastric Digestion?
74.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.9K
Chronic Bowel Disorders: Introduction
744
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
744
Inflammatory Bowel Disease IV: Pharmacological Management
496
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
496


